Clinical study results of the new formulation leuprorelin acetate three-month depot for the treatment of advanced prostate carcinoma. (Q53994827)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Clinical study results of the new formulation leuprorelin acetate three-month depot for the treatment of advanced prostate carcinoma. |
scientific article |
Statements
Clinical study results of the new formulation leuprorelin acetate three-month depot for the treatment of advanced prostate carcinoma. (English)
Fornara P
Jocham D
1 January 1996
56 Suppl 1
18-22